Universal-Beteiligungs- und Servicegesellschaft’s Legend Biotech LEGN Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$938K	Sell	32,467 -10,260	-24%	-$277K	﹤0.01%	1593
2026 Q1	$773K	Buy	42,727 +6,886	+19%	+$131K	﹤0.01%	1599
2025 Q4	$779K	Buy	35,841 +3,699	+12%	+$106K	﹤0.01%	1574
2025 Q3	$1.05M	Buy	32,142 +7,200	+29%	+$266K	﹤0.01%	1533
2025 Q2	$885K	Buy	24,942 +173	+0.7%	+$5.61K	﹤0.01%	1528
2025 Q1	$840K	Buy	24,769 +922	+4%	+$33.1K	﹤0.01%	1511
2024 Q4	$776K	Buy	+23,847	New	+$988K	﹤0.01%	954

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's LEGN Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Legend Biotech (LEGN) stake by 24% in Q2 2026, selling an estimated $277K and leaving 32,467 shares worth $938K. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in LEGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.05M in Q3 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 32,467 shares of Legend Biotech worth $938K as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 10,260 Legend Biotech shares in Q2 2026, an estimated $277K.
Legend Biotech made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1593 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Legend Biotech in Q4 2024 and has held it in 7 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's Legend Biotech position peaked at $1.05M in Q3 2025.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.